期刊文献+

老年2型糖尿病女性骨质疏松状况及其影响因素 被引量:24

Prevalence of osteoporosis and factors affecting bone mineral density in elderly women with type 2 diabetes mellitus
原文传递
导出
摘要 目的探讨老年2型糖尿病(T2DM)女性骨质疏松状况及影响因素。方法2011年1月到2012年2月人组167例老年T2DM女性患者及138名老年健康女性(对照组)。对两组受试者进行健康问卷调查,并检测其骨密度(BMD)和生化、骨代谢指标。应用多因素Logistic回归、多元相关与回归分析该人群骨质疏松情况及其影响因素。结果T2DM组167例,年龄60~78岁;对照组138例,年龄60~80岁。老年T2DM女性骨量减低和骨质疏松者共占85.6%(143/167),显著低于对照组的97.1%f134/138)(X2=11.929,P=0.001)。T2DM组发生低骨量和骨折的风险分别是对照组的0.178倍和1.776倍。以骨量减低为因变量,锻炼频率、锻炼年限和体质指数(BMI)进入多因素Logistic回归方程,回归系数为:-0.438、-0.840、-0.297,均P〈0.05。T2DM未进入该方程但进入了以骨折为因变量的多因素Logistic回归方程。T2DM组酒石酸酸性磷酸酶5b、尿羟脯氨酸/肌酐比值显著高于对照组(校正BMI和生活方式后F=3.818、1.541,均P〈0.05),而骨钙素和骨特异性碱性磷酸酶则显著低于对照组(校正BMI和生活方式后F=0.407、0.920,均P〈0.05)。结论老年T2DM女性发生低骨量的风险低于对照组,但骨折发生率高;其骨代谢特征是骨吸收增加且骨形成减少,症状则更加隐匿。 Objective To investigate the prevalence of osteoporosis in elderly women with type 2 diabetes mellitus(T2DM) and associated factors. Methods From January 2011 to February 2012, 167 elderly women with T2DM and 138 healthy elderly women (controls) were enrolled in this study. The medical history, bone densitometry and biochemical indicators were recorded in the two groups. Data were analyzed with multivariate logistic regression and multiple regression analysis to identify the impacting factors of the osteoporosis in the elderly female patients with T2DM. Results There were 167 elderly women in T2DM group, aged 60-78 years; and 138 elderly women in control group, aged 60-80 years. Total incidence of oste0penia and osteoporosis in T2DM group (85.6%(143/167)) was lower than that in control group(97.1% (134/138))(XZ=11.929, P=0.001). The risk of developing low bone mass and fracture in T2DM group was 0.178 and 1.776 times of that in control group, respectively. Set low bone mass as dependent variable, the variables of frequency of physical exercise, duration of physical exercise and body mass index(BMI) entered the logistic regression equation, and the regression coefficients B were- 0.438,- 0.840 and- 0.297, respectively, all P〈0.05. T2DM was excluded from this equation, but it entered the logistic regression equation with fracture as dependent variable. The levels of tartrate-resistant acid phosphatase 5b and urinary hydroxyproline/creatinine were higher in T2DM group than those in control group(adjusted for BMI and life style, F=3.818, 1.541, both P〈0.05). While the levels of bone glaprotein and bone-specific alkaline phosphatase were lower in T2DM group than those in control participants (adjusted for BMI and life style, F= 0.407, 0.920, both P〈0.05). Conclusion The risk of developing low bone mass is lower in elderly women with T2DM than the control participants, but the risk for fracture is higher, and the osteoporosis in these patients is more difficult to be identified.
出处 《中华糖尿病杂志》 CAS CSCD 2016年第8期493-498,共6页 CHINESE JOURNAL OF DIABETES MELLITUS
基金 北京市卫生局中央保健专项资金科研课题(京06-09)
关键词 糖尿病 2型 骨密度 骨质疏松 骨质丢失 Diabetes ,nellitus, type 2 Bone density Osteoporosis Bone loss
  • 引文网络
  • 相关文献

参考文献18

  • 1Kanis JA, McCloskey EV, Johansson H, et al. Europeanguidance for the diagnosis and management of osteoporosis inpostmenopausal w()men[J]. Osteoporos Int, 2013,24(1):23-57.D01:10.1007/s00198-012~2074-y.
  • 2Pierce MB, Silverwood RJ, Nitsch D, et al. Clinical disordersin a post war British cohort reaching retirement: evidence fromthe first National Birth Cohort study[J]. PLoS One, 2012, 7(9):e44857. DOI: 10.1371 /journal.pone.0044857.
  • 3Wen CY, Chen Y, Tang HL, et al. Bone loss at subchondralplate in knee osteoarthritis patients with hypertension andtype 2 diabetes mellitus[J]. Osteoarthritis Cartilage, 2013, 21(11):1716-1723. DOI: 10.1016/j.joca.2013.06.027.
  • 4Dhaon P, Shah VN. Type 1 diabetes and osteoporosis: areview of literature[J]. Indian J Endocrinol Metab, 2014,18(2):159-165. DOI: 10.4103/2230-8210.129105.
  • 5Neglia C, Agnello N, Argentiero A, et al. Increased risk ofosteoporosis in postmenopausal women with type 2 diabetesmellitus: a three-year longitudinal study with phalangeal QUSmeasurements[J]. J Biol Regul Homeost Agents, 2014,28(4):733-741.
  • 6Chen HL, Deng LL, Li JF. Prevalence of osteoporosis and itsassociated factors among older men with type 2 diabetes[J]. Int JEndocrinol, 2013, 2013:285729. DOI: 10.1155/2013/285729.
  • 7Assessment of fracture risk and its application to screening forpostmenopausal osteoporosis: report of a WHO Study Group[J]. World Health Organ Tech Hep Ser, 1994, 843:1-129.
  • 8徐飞,董永辉,黄鑫,郭风劲,陈安民,黄仕龙.2型糖尿病对小鼠骨代谢的影响[J].中国骨质疏松杂志,2014,20(3):238-241. 被引量:6
  • 9Dhaliwal R,Cibula D, Ghosh C, et al. Bone qualityassessment in type 2 diabetes mellitus[J]. Osteoporos Int,2014, 25(7):1969-1973. DOI: 10.1007/s00i98-014-2704_7.
  • 10Afshinnia F, Chacko S, Zahedi T. Association of lower serumcholesterol levels with higher risk of osteoporosis in type 2dial)etes[J]. Endocr Pract, 2007,13(6):620-628. DOI: 10.4158/EP. 13.6.620.

二级参考文献91

  • 1陈悦,周建烈.维生素D缺乏的流行病学研究进展[J].中华临床营养杂志,2009,17(5). 被引量:29
  • 2戴荣峰,金晖,孙子林.糖基化终产物对小鼠成骨样细胞基质金属蛋白酶诱导物基因表达的影响[J].江苏医药,2007,33(9):913-915. 被引量:5
  • 3Shan P F, Shan P F, Wu X P, et al. Age-related bone mineral density, osteoporosis rate and risk of vertebral fracture inmainland Chinese women with type 2 diabetes mellitus. J Endocrinol Invest, 2011, 34(3):190-196.
  • 4R akel A, Sheehy O, Rahme E, et al. Osteoporosis among patients with type 1 and type 2 diabetes. Diabetes MeTab, 2008, 34(3) :193-205.
  • 5Mascitelli L, Pezzetta F. Type 2 diabetes and fracture risk. Lancet, 2006, 368 (9537) :732.
  • 6Yaturu S, Humphrey S, Landry C, et al. Decreased bone mineral density in men with metabolic syndrome alone and with type 2 diabetes. Med Sci Monit, 2009, 15 ( 1 ) : CR5-9.
  • 7Halleen JM. Tartrate-resistant acid phosphatase 5B is a specific and sensitive marker of bone resorption. Anticancer Res, 2003, 23(2A) :1027-1029.
  • 8Reginster JY, Collette J, Neuprez A, et al. Role of biochemical markers of bone turnover as prognostic indicator of successful osteoporosis therapy. Bone, 2008, 42(5) :832-836.
  • 9Feng Zhengping, Deng Huacong, Du Jia, et al. Lentiviral- mediated RNAi targeting p38MAPK ameliorates high glucose-induced apoptosis in osteoblast MC3TS-E1 cell line. Indian J. Exp. Biol, 2011, 49(2) : 94-104.
  • 10Garcia-Hern6ndez A, Arzate H, Gil-Chavarria I, et al. High glucose concentrations alter the biomineralization process in human osteoblastic cells. Bone, 2012, 50(I ):276-285.

共引文献220

同被引文献193

引证文献24

二级引证文献202

;
使用帮助 返回顶部